Photodynamic Therapy of Acne Vulgaris - a Randomized Blinded Controlled Study

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00206895

Enrollment

Registered

2005-09-21

Start date

2004-11-30

Completion date

Unknown

Last updated

2006-10-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acne Vulgaris

Brief summary

The purpose of the study is to evaluated the efficacy and tolerability of methyl aminolevulinate and 5-aminolevulinic acid photodynamic therapy in patients with moderate to severe facial acne vulgaris in a randomized controlled and investigator blinded trial.

Interventions

PROCEDUREPhotodynamic therapy

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Inclusion criteria

18 years or older, good health, more than 12 inflammatory facial acne lesions -

Exclusion criteria

skin type VI, pregnant or lactating woman. Oral retinoid use within one year, systemic antibiotics within 1 month, topical acne treatment within 2 weeks. \-

Design outcomes

Primary

Measure	Time frame
Leeds Revised Acne Grading System	—
Lesion counts (non-inflammatory and inflammatory)	—

Secondary

Measure	Time frame
Pain	—
Side effects	—

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026